The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Open accessAbstract
With a political debate about the potential risks and benefits of cannabis use as a backdrop, the wave of legalization and liberalization initiatives continues to spread. Four states (Colorado, Washington, Oregon, and Alaska) and the District of Columbia have passed laws that legalized cannabis for recreational use by adults, and 23 others plus the District of Columbia now regulate cannabis use for medical purposes. These policy changes could trigger a broad range of unintended consequences, with profound and lasting implications for the health and social systems in our country. Cannabis use is emerging as one among many interacting factors that can affect brain development and mental function. To inform the political discourse with scientific evidence, the literature was reviewed to identify what is known and not known about the effects of cannabis use on human behavior, including cognition, motivation, and psychosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It manifests as a reduce motivation to engage in everyday activities such as a diminished desire to study or work, engage in social or recreational activities people who use cannabis frequently [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Specifically, chronic cannabis users have smaller volumes of the orbitofrontal cortex, a brain region implicated in motivation, and the hippocampus, a brain area implicated in stress, learning and memory [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Cannabis users and people intoxicated with THC had altered function in the same regions and in brain striatal areas implicated in reward processing.”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
In the citing paper
“Specifically, chronic cannabis users have smaller volumes of the orbitofrontal cortex, a brain region implicated in motivation, and the hippocampus, a brain area implicated in stress, learning and memory [32].”
From Cannabis, cannabinoids and health: a review of evidence on risks and medical benefits (2025) · cites this paper as [32]
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?
Berridge, K. C., & Robinson, T. E. (1998) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00019-8 · Cited by 4,127
Endocannabinoid-Mediated Control of Synaptic Transmission
Kano, M., Ohno‐Shosaku, T., Hashimotodani, Y., Uchigashima, M., & Watanabe, M. (2009) · Physiological Reviews · doi:10.1152/physrev.00019.2008 · Cited by 1,595
Persistent cannabis users show neuropsychological decline from childhood to midlife
Meier, M. H., Caspi, A., Ambler, A., Harrington, H., Houts, R., Keefe, R. S. E., McDonald, K., Ward, A., Poulton, R., & Moffitt, T. E. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206820109 · Cited by 1,523
Self-citationCaspi, A., Moffitt, T. E., Cannon, M., McClay, J., Murray, R., Harrington, H., Taylor, A., Arseneault, L., Williams, B., Braithwaite, A., et al. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.026 · Cited by 1,409
Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study.
Arseneault, L., Cannon, M., Poulton, R., Murray, R., Caspi, A., & Moffitt, T. E. (2002) · BMJ · doi:10.1136/bmj.325.7374.1212 · Cited by 1,399
Cannabis and schizophrenia. A longitudinal study of Swedish conscripts
Andréasson, S., Engström, A., Allebeck, P., & Rydberg, U. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92620-1 · Cited by 1,166
Apathy: a neuropsychiatric syndrome
Marin, R. S. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.3.243 · Cited by 1,088
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Cannabis use and psychosis: A longitudinal population-based study
van Os, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf043 · Cited by 928
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 865
The Treatment of Cannabis Use Disorder
Danovitch, I., & Gorelick, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54856-4.00007-9 · Cited by 5
Monoacylglycerol lipase inhibition as potential treatment for interstitial cystitis
Chinnadurai, A., Berger, G., Burkovskiy, I., Zhou, J., Cox, A. R., Lynch, M., & Lehmann, C. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.109321 · Cited by 5
Gould, J. M., Greene, D. S., & Donnelly, R. J. (2020) · Journal of Drug Issues · doi:10.1177/0022042620911367 · Cited by 5
Cognitive functioning and cannabis use in first-episode psychosis
Karpov, B., Lindgren, M., Kieseppä, T., Wegelius, A., & Suvisaari, J. (2021) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2021.2018038 · Cited by 5
Combinatorial approaches for treating neuropsychiatric social impairment
Don, W., Tsheringla, S., McPartland, J. C., & Allsop, S. A. (2022) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2021.0051 · Cited by 6
Chahkandi, M., Komeili, G., Sepehri, G., Khaksari, M., & Amiresmaili, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119723 · Cited by 5
Cannabis, a potential treatment option in pediatric IBD? Still a long way to go
Halbmeijer, N. M., Groeneweg, M., & de Ridder, L. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1582330 · Cited by 5
Where Are We and Where Are We Going?
Iversen, L. L. (2018) · Oxford University Press eBooks · doi:10.1093/oso/9780190846848.003.0008 · Cited by 5
Nicholas, L. H., & Maclean, J. C. (2016) · National Bureau of Economic Research · doi:10.3386/w22688 · Cited by 7
Challenging the Association of Marijuana Laws With Teen Marijuana Use
Jones, C. M., Underwood, J. M., & Volkow, N. D. (2019) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/jamapediatrics.2019.4235 · Cited by 5
Self-citationMedical cannabis for chronic pain
Kröger, E., & Dionne, C. E. (2021) · BMJ · doi:10.1136/bmj.n1942 · Cited by 6
Outdated tools, underestimated harm: Modernizing cannabis surveillance in a post‐legalization era
Bahji, A. (2025) · Addiction · doi:10.1111/add.70274 · Cited by 4
Davis, A. K., Arterberry, B. J., Xin, Y., Hubbard, S. M., Schwarting, C. M., & Bonar, E. E. (2023) · Cannabis · doi:10.26828/cannabis/2023/000180 · Cited by 4
Andica, C., Kamagata, K., Takabayashi, K., Mahemuti, Z., Hagiwara, A., & Aoki, S. (2024) · American Journal of Neuroradiology · doi:10.3174/ajnr.a8215 · Cited by 4
A Systematic Review of Delta-9-Tetrahydrocannabinol (∆9-THC) in Astrocytic Markers
Ramos-Jiménez, C., Petkau, S., & Mizrahi, R. (2024) · Cells · doi:10.3390/cells13191628 · Cited by 4
Brassard, S. L., Dosanjh, J., Cooper, J. A., Weber, J., Zald, D. H., MacKillop, J., & Balodis, I. M. (2025) · Cognitive Affective & Behavioral Neuroscience · doi:10.3758/s13415-025-01308-x · Cited by 4
Delile, J., & Couteron, J.-P. (2017) · Pratiques en santé mentale · doi:10.3917/psm.172.0009 · Cited by 4
Dellazizzo, L., Potvin, S., Giguère, S., & Dumais, A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0163 · Cited by 4
Rudroff, T., Workman, C. D., Gander, P. E., Deters, J. R., & Ponto, L. L. B. (2022) · Brain Sciences · doi:10.3390/brainsci12070819 · Cited by 5
Synthetic cannabinoids impact on cognitive functions
Elrassas, H. H., Elsayed, Y. A. R., Abdeen, M. S., Mohamed, A. T., & Nagar, Z. M. E. (2023) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-023-00756-x · Cited by 4
The Role of Cannabis in the Development of Psychosis
Ertuğrul, A., & Türkoğlu, Ö. (2023) · Turkish Journal of Psychiatry · doi:10.5080/u27122 · Cited by 5
Gravely, S. M. L., Driezen, P., Shahab, L., McClure, E. A., Hyland, A. J., Cummings, K. M., East, K. A., Chan, G., Walsh, H., Benowitz, N. L., et al. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01214-8 · Cited by 4
Zellers, S. M., Alexander, J. D., Ellingson, J. M., Schaefer, J. D., Corley, R. P., Iacono, W. G., Hewitt, J. K., Hopfer, C. J., McGue, M. K., & Vrieze, S. I. (2023) · Journal of Psychopathology and Clinical Science · doi:10.1037/abn0000867 · Cited by 5
The risk of cannabis use disorder is mediated by altered brain connectivity: A chronnectome study
Fazio, G., Olivo, D., Wolf, N. D., Hirjak, D., Schmitgen, M. M., Werler, F., Wittemann, M., Kubera, K. M., Calhoun, V. D., Reith, W., et al. (2024) · Addiction Biology · doi:10.1111/adb.13395 · Cited by 4
Cardiac Transplantation and the Use of Cannabis
Shah, H., Fraser, M., Agdamag, A. C., Maharaj, V., Nzemenoh, B. N., Martin, C. M., Alexy, T., & Garry, D. J. (2021) · Life · doi:10.3390/life11101063 · Cited by 4
Changes in Medical Cannabis Use After Recreational Cannabis Legalization in Canada
Nguyen, H. V., Grootendorst, P. V., Mital, S., Bishop, L. D., & McGinty, E. E. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0227 · Cited by 4
Freichel, R., Kroon, E., Kuhns, L., Filbey, F. M., Veer, I. M., Wiers, R. W. H. J., & Cousijn, J. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0239 · Cited by 4
Cannabis Medicinal: Uma Revisão sobre as Perspectivas Atuais e Desafios Futuros na Prática Clínica
Viana, T. R. X., Venute, L. D. P., Coelho, A. T., Souza, D., de Deus, R. X., Cesar, A. C., Pontes, E. A. S., Alves, V. C., & dos Santos, J. R. (2024) · Journal of Research in Medicine and Health · doi:10.52832/jormed.v2.403 · Cited by 4
Cannabinoid Use and Depression: Comparison of Natural and Synthetic Cannabinoids
Akdeniz, G. S., & Sait, S. C. (2020) · Clinical Medical Reviews and Case Reports · doi:10.23937/2378-3656/1410298 · Cited by 4
Opioid-Induced Psychosis in a Patient With Sickle Cell Disease
Tumenta, T., Thanju, A., Perera, P., Kallikkadan, J., Fouron, P., & Olupona, T. (2021) · Cureus · doi:10.7759/cureus.15557 · Cited by 4
Cannabinoid-Related Adverse Events and Impairment
MacCallum, C. A., de Freitas, L., Lo, L. A., Eadie, L., & Brubacher, J. R. (2021) · Springer eBooks · doi:10.1007/978-3-030-69186-8_36 · Cited by 4
Biomedical Research on Substances of Abuse: The Italian Case Study
Magliaro, C., & Ahluwalia, A. D. (2022) · Alternatives to Laboratory Animals · doi:10.1177/02611929221132215 · Cited by 5
Šestan-Peša, M., Shanabrough, M., Horváth, T. L., & Miletta, M. C. (2023) · Biomedicines · doi:10.3390/biomedicines11010144 · Cited by 5
Cognitive rehabilitation in psychiatry
Shah, U. (2017) · Annals of Indian Psychiatry · doi:10.4103/aip.aip_35_17 · Cited by 4
Bloomfield, M., Petrilli, K., Lees, R., Hindocha, C., Beck, K., Turner, R. J., Onwordi, E. C., Rane, N., Lythgoe, D. J., Stone, J. M., et al. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.04.013 · Cited by 4
Self-citationBaranger, D. A. A., & Bogdan, R. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.05.018 · Cited by 4
Die neue Cannabis-Regulierung in Deutschland: Desaster oder Chance?
Klosterkötter, J., & Kuhn, J. (2024) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/a-2332-6635 · Cited by 4
Graupensperger, S. A., Janson, M. A., Fairlie, A. M., Larimer, M. E., & Lee, C. M. (2025) · Prevention Science · doi:10.1007/s11121-025-01846-3 · Cited by 3
Comprehensive interventions for reducing cannabis use
Tirado-Muñoz, J., Mestre-Pintó, J. I., Farré, M., Fonseca, F., & Torrens, M. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000430 · Cited by 3
Conductas adictivas (excluido el tabaco)
Karila, L., Coscas, S., Hermand, M., Lafaye, G., Donnadieu‐Rigole, H., & Benyamina, A. (2020) · EMC - Tratado de Medicina · doi:10.1016/s1636-5410(20)44305-3 · Cited by 3
Göç ve Bağımlılık: Suriyeli Göçmenlerin Madde Kullanım Süreçlerine Dair Nitel Bir Araştırma
ŞAHİN, M., & Güngör, F. (2022) · İçtimaiyat · doi:10.33709/ictimaiyat.1111559 · Cited by 3
Mmethi, T. G., Modjadji, P., Mathibe, M., Thovhogi, N., Sekgala, M. D., Madiba, T. K., & Ayo-Yusuf, O. A. (2024) · Behavioral Sciences · doi:10.3390/bs14070543 · Cited by 4
Patterns of substance use on a given day in a national sample of U.S. young adults
Evans‐Polce, R. J., Arterberry, B. J., Lanza, S. T., & Patrick, M. E. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108376 · Cited by 3
Video gaming and cannabis use: A scoping review
Jobin, E. Y., Légaré, A.-A., Lehmann, K., & Monson, E. (2025) · Journal of Behavioral Addictions · doi:10.1556/2006.2025.00040 · Cited by 3
Demattéis, M., Pennel, L., Dubreucq, J., Giraud-Baro, É., & Brousse, G. (2018) · Elsevier eBooks · doi:10.1016/b978-2-294-75915-4.00043-8 · Cited by 3
Stiles, M., & Rice, C. (2018) · Journal of Human Behavior in the Social Environment · doi:10.1080/10911359.2018.1496866 · Cited by 3
Demirci, H. B., Acar, S., & Akgür, S. A. (2020) · The Bulletin of Legal Medicine · doi:10.17986/blm.2020.v25i1.1366 · Cited by 3
Working with clients who self-medicate using cannabis: Mind the gap in knowledge.
Feingold, D. (2020) · Professional Psychology Research and Practice · doi:10.1037/pro0000345 · Cited by 3
Do schizotypy features predict cannabis problems in partnered community adults?
Brown, W. C., Leonard, K. E., Stasiewicz, P. R., & Testa, M. (2021) · Addictive Behaviors · doi:10.1016/j.addbeh.2021.106819 · Cited by 3
Chronic cannabis use affects cerebellum dependent visuomotor adaptation
Blithikioti, C., Miquel, L., Paniello-Castillo, B., Nuño, L., Gual, A., Ballester, B. R., Fernandez, A., Herreros, I., Verschure, P. F. M. J., & Balcells-Olivero, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.10.007 · Cited by 4
Anderson, M. A. B., Budney, A. J., Jacobson, N. C., Nahum-Shani, I. B., & Stanger, C. (2022) · JMIR Formative Research · doi:10.2196/40139 · Cited by 3
Weinstein, A. M. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1230760 · Cited by 4
Mennis, J. L., Stahler, G. J., & Coffman, D. L. (2024) · Substance Use & Misuse · doi:10.1080/10826084.2024.2310500 · Cited by 4
Coudevylle, G. R., Collado, A., Sinnapah, S., Kotbagi, G., & Bouchard, J. (2023) · La Revue de l Infirmière · doi:10.1016/j.revinf.2023.07.013 · Cited by 3
Psychotomimetic and Cognitive Effects of Cannabis Use in the General Population
Solowij, N. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804791-0.00005-7 · Cited by 3
Important Questions About the Impact of Medical Marijuana on People With Serious Mental Illness
Brunette, M. F., Borodovsky, J. T., Myers, M. A., & Budney, A. J. (2018) · Psychiatric Services · doi:10.1176/appi.ps.201800210 · Cited by 3
Burger, T. J., Schirmbeck, F. N., Vermeulen, J. M., Quee, P. J., de Koning, M. B., Bruggeman, R., de Haan, L., & GROUP investigator (2020) · Psychological Medicine · doi:10.1017/s0033291720000719 · Cited by 3
Fischer, B., Daldegan‐Bueno, D., Bell, R., Boden, J. M., Bullen, C., Farrell, M., Hall, W., & Newcombe, D. A. L. (2020) · Public Health in Practice · doi:10.1016/j.puhip.2020.100046 · Cited by 3
Zwicker, A., LeBlanc, M. A., Pavlová, B., Alda, M., Denovan‐Wright, E. M., Uher, R., & Austin, J. (2020) · Early Intervention in Psychiatry · doi:10.1111/eip.13082 · Cited by 3
Fuentes-Verdugo, E., López-Tolsa, G. E., Pellón, R., & Miguéns, M. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05952-2 · Cited by 3
Penzel, N., Sanfelici, R., Antonucci, L. A., Betz, L. T., Dwyer, D., Ruef, A., Cho, K. I. K., Cumming, P. D., Pogarell, O. M., Howes, O. D., et al. (2022) · Schizophrenia · doi:10.1038/s41537-022-00218-y · Cited by 3
Association Between Cannabis Smoking and Academic Achievement in High-School Students
Pérez-Martínez, Y., Ospino, G. A. C., & Campo‐Arias, A. (2022) · The Open Psychology Journal · doi:10.2174/18743501-v15-e2209210 · Cited by 3
Brief Interventions for Cannabis Using Adolescents
Winters, K. C., Waldron, H. B., Hops, H., Ozechowski, T. J., & Montano, A. (2022) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2022.06.004 · Cited by 3
Vogel, M., Nikoo, M., Nikoo, N., Schütz, C. G., Walter, M., Somers, J. M., & Krausz, M. R. (2018) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-018-0040-4 · Cited by 3
Perlmutter, A. S., Keyes, K. M., Giovenco, D. P., Martins, S. S., & Rudolph, K. E. (2024) · American Journal of Epidemiology · doi:10.1093/aje/kwae189 · Cited by 2
Kennedy, L., Ku, B. S., Addington, J., Amir, C., Bearden, C. E., Cannon, T. D., Carrión, R. E., Cornblatt, B. A., Keshavan, M. S., Perkins, D. O., et al. (2024) · Schizophrenia Research · doi:10.1016/j.schres.2024.07.032 · Cited by 2
Chen, M. Y., Skrzynski, C. J., Bidwell, L. C., & Bryan, A. D. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108399 · Cited by 2
Khan, M. T. F., Mazumder, S., Rana, M. S., & Rahman, M. M. (2025) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-025-01520-3 · Cited by 2
Kumar, L., Spindle, T. R., Zamarripa, C. A., Elder, H., Russo, E. B., Bigelow, G. E., & Vandrey, R. G. (2025) · Medical Cannabis and Cannabinoids · doi:10.1159/000547014 · Cited by 2
Neves, A. M., Leal, S. M., Fonseca, B. M., & Sá, S. I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136144 · Cited by 2
Ebling, T., de Silva, G. S. R., & Azagba, S. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108476 · Cited by 2
Meng, S., Capria, K. L., Stafford, M. R., Yang, C., Padon, A. A., Jackson, K. M., & Chen-Sankey, J. C. (2025) · Addictive Behaviors · doi:10.1016/j.addbeh.2025.108475 · Cited by 2
Grether, U. (2025) · Pharmaceuticals · doi:10.3390/ph18091324 · Cited by 3
Mizuno, S., Inoura, S., Matsumoto, T., Kitagaki, K., Koide, A., Takehara, K., & Shimane, T. (2025) · Psychiatry and Clinical Neurosciences Reports · doi:10.1002/pcn5.70241 · Cited by 2
Murri, M. B., Guglielmo, R., Zizzi, A., Muscettola, A., Nanni, M. G., Dall’Oro, M., Serafini, G., Inuggi, A., Escelsior, A., Amore, M., et al. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106517 · Cited by 2
PET imaging of FAAH in chronic Cannabis users: longitudinal assessment during short-term abstinence
Poluga, C., Dheda, S. S., Boachie, N., McCluskey, T., Narciso, L., Zilberman, M., Cote, C., Huestis, M. A., Tyndale, R. F., Kloiber, S. M., et al. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02438-7 · Cited by 2
Gahr, M., Hiemke, C., Connemann, B. J., & Schönfeldt‐Lecuona, C. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000707 · Cited by 2
Nelson, D. M., Douglas, J., Sunga, P., & Smith, D. I. (2020) · Cannabis · doi:10.26828/cannabis.2020.01.005 · Cited by 2
Lee, J. Y., Pahl, K., & Kim, W. (2020) · Journal of Substance Use · doi:10.1080/14659891.2020.1784301 · Cited by 2
Kalan, M. E., Jebai, R., Li, W., Gautam, P., Osibogun, O., Alqahtani, M., Ward, K., Behaleh, R., Bursac, Z., & Taleb, Z. B. (2023) · Substance Use & Misuse · doi:10.1080/10826084.2023.2177966 · Cited by 2
Beaudoin, M., Dellazizzo, L., Giguère, S., Guay, J., Giguère, C., Potvin, S., & Dumais, A. (2023) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0038 · Cited by 3
Gawrysiak, M. J., Loomis, D., Armao, M., Gillooly, E., Kearns, L., & Walsh, J. C. (2023) · Mindfulness · doi:10.1007/s12671-023-02136-1 · Cited by 2
Azofeifa, A., Mattson, M. E., Fogarty, K. J., & Lyerla, R. (2023) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-023-01137-4 · Cited by 2
Mobile app measuring sleep and behaviors: A trial in adolescents with addiction
Pitrat, B., Turpin, A., Peyret, E., Hamonnière, T., Drain, A., Maatoug, R., & Roux, É. L. (2024) · L Encéphale · doi:10.1016/j.encep.2023.11.007 · Cited by 3
Oliveras, C., Cortez, P., Nuno, L., Colom, J., Kögel, C. C., Pascual, F., Fernández‐Artamendi, S., Gual, A., Balcells‐Oliveró, M., & López‐Pelayo, H. (2024) · European Addiction Research · doi:10.1159/000540541 · Cited by 2
Fear of COVID-19 and illicit drug use during COVID-19 pandemic in Japan: a case-control study
Nitta, K., Naito, H., Tabuchi, T., & Kakiuchi, Y. (2024) · PeerJ · doi:10.7717/peerj.18137 · Cited by 2
The Relationship of glutamate signaling to cannabis use and schizophrenia
Niznikiewicz, M. A., Lin, A. P., & DeLisi, L. E. (2025) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000001003 · Cited by 3
Self-citationDonate, A. P. G., Cousijn, J., Kroon, E., & Thomsen, K. R. (2026) · Addiction · doi:10.1111/add.70525 · Cited by 2
Pérez, G. A. C., Becoña, E., Escobar, S. M. R., & Scoppetta, O. (2019) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-019-00132-y · Cited by 2
Role of Cannabinoid Receptors in Psychological Disorder
Jha, A. N., & Patel, D. M. (2020) · Borneo Journal of Pharmacy · doi:10.33084/bjop.v3i4.1569 · Cited by 2
Lim, C., Paudel, S., Holt, D. J., & Freudenreich, O. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-11844-9.00027-8 · Cited by 2
Rossi, P. C., Gil, E. B., Costela, V., & Torrens, M. (2017) · Adicciones · doi:10.20882/adicciones.810 · Cited by 2
Schizophrenia and substance abuse
DeLisi, L. E., & Fleischhacker, W. W. (2017) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000328 · Cited by 2
Self-citationLipid Mediators in the Regulation of Emotions, Memory, and Cognitive Functions
Lutz, B. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_6 · Cited by 2
Clingan, S. E., & Woodruff, S. I. (2017) · Substance Use & Misuse · doi:10.1080/10826084.2017.1305412 · Cited by 2
Introduction to Cannabis Use Disorders
Montoya, I. D., & Weiss, S. R. B. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_1 · Cited by 3
Janero, D. R., Vemuri, K. V., & Makriyannis, A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_6 · Cited by 2
Clinical Manifestations of Cannabis Use Disorder
Budney, A. J., Borodovsky, J. T., & Knapp, A. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-90365-1_10 · Cited by 2
Narrative Review of Cannabidiol as an Antipsychotic and Recommendations for Legal Regulations
Walkey, L. R. L., Tanguay, R. L., & el‐Guebaly, N. (2018) · The Canadian Journal of Addiction · doi:10.1097/cxa.0000000000000026 · Cited by 2
Genetic Risk of Psychosis in Relation to Cannabis Use: Findings from Polygenic Risk Score Approaches
Adorjan, K., & Papiol, S. (2019) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20190018 · Cited by 3
Metadata
- Authors
- Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R.
- Affiliations
- National Institutes of Health (US)
- University of California, Irvine (US)
- Harvard University (US)
- Arizona State University (US)
- Center for Children and Families, Department of Psychology, Florida International University, Miami
- Hammersmith Hospital (GB)
- University College London (GB)
- National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland
- ORCID
- Venue
- JAMA Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 2016-03-01
- Volume
- 73
- Issue
- 3
- Pages
- 292
- ISSN
- 2168-622X (ISSN-L)
- OpenAlex
- W2264173627
- Cited by
- 867
- References
- 77
- Citations by year
- 2026: 46 · 2025: 85 · 2024: 64 · 2023: 85 · 2022: 81 · 2021: 87 · 2020: 105 · 2019: 102 · 2018: 97 · 2017: 74 · 2016: 40
- FWCI
- 84.45
- Type
- journal article
- Language
- en
- Open access
- green
- discovery.ucl.ac.uk
- Locations
- JAMA Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Bank (Australian Catholic University) (submittedVersion)
- Funders
- FORUM Pharmaceuticals
- National Institute for Health and Care Research (CL-2015-18-005, ACF-2014-18-010)
- British Medical Association
- National Institutes of Health
- Medical Research Council (MR/K015524/1)
- National Institute on Drug Abuse (R01DA021576, R01DA021245, R01DA030992)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Keywords
- cannabis use, recreational cannabis legalization, medical cannabis, cognition, motivation, psychosis, brain development, mental health, cannabis policy
- MeSH terms
- Adult, Behavior, Cannabis, Marijuana Abuse, Cognition, Humans, Legislation, Drug, Motivation, Psychoses, Substance-Induced, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review